Skip to content
Tech News
← Back to articles

Author Correction: A µ-opioid receptor superagonist analgesic with minimal adverse effects

read original more articles
Why This Matters

This correction highlights ongoing advancements in opioid research, emphasizing the development of safer analgesics with fewer adverse effects. Such innovations are crucial for addressing the opioid crisis and improving pain management for consumers. The research underscores the importance of responsible scientific communication and licensing in disseminating medical breakthroughs.

Key Takeaways

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions